Evaluation of the efficacy and safety of initial high-dose romiplostim for primary immune thrombocytopenia in the acute care setting
1. 请及时下载文件确认是否正确, 系统将在 2026-01-19 17:00:54 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1097/MBC.0000000000001397
文献链接: https://journals.lww.com/10.1097/MBC.0000000000001397
其他信息:
出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Grace Bringhurst; P. Christopher Parish; Hang Zeng; Danielle Boselli; Joseph B. Elmes; Donald C. Moore; Justin R. Arnall

